DEXCOM INC

Surgical & Medical Instruments & Apparatus·SAN DIEGO, CA·FY end 12/31·CIK 1093557

CEO Pay Ratio

278:1

Jacob Leach

CEO Total Comp

$8.0M

Jacob Leach

Median Employee

$58,663

Revenue

$4.7B

FY 2025

Net Income

$836.3M

FY 2025

Free Cash Flow

$1.1B

FY 2025

Net Margin

17.9%

Insider Net (180d)

0 buys / 0 sales

CEO Pay Accountability

CEO comp as % of net income

0.95%

For every $1,000 of profit, $9.55 flows to the CEO.

CEO comp as % of buybacks

1.60%

CEO comp equals 16.0‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$4.7B	$4.0B	$3.6B	$2.9B	$2.4B
Gross Profit	$2.8B	$2.4B	$2.3B	$1.9B	$1.7B
Operating Income	$911.8M	$600.0M	$597.7M	$391.2M	$265.8M
Net Income	$836.3M	$576.2M	$541.5M	$341.2M	$154.7M
Operating CF	$1.4B	$989.5M	$748.5M	$669.5M	$442.5M
Capex	$363.5M	$358.8M	$236.6M	$364.8M	$389.2M
Free Cash Flow	$1.1B	$630.7M	$511.9M	$304.7M	$53.3M
Buybacks	$500.0M	$750.0M	$188.7M	$557.7M	—
Dividends	—	—	—	—	—	—

Gross Margin	60.1%	60.5%	63.2%	64.7%	68.6%
Operating Margin	19.6%	14.9%	16.5%	13.4%	10.9%
Net Margin	17.9%	14.3%	14.9%	11.7%	6.3%
FCF Margin	23.1%	15.6%	14.1%	10.5%	2.2%
R&D / Revenue	12.9%	13.7%	14.0%	16.6%	21.1%
Effective Tax	23.2%	18.7%	23.8%	12.7%	11.0%
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	46.4%	118.9%	36.9%	183.0%	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Kevin SayerExecutive Chairman	$1.2M	$13.9M	—	$1.1M	$70.9K	$16.3M
Jacob LeachPresident & Chief Executive Officer	$769.0K	$5.9M	—	$1.2M	$116.2K	$8.0M
Jereme SylvainEVP, Chief Financial Officer	$646.6K	$5.9M	—	$465.6K	$29.6K	$7.1M
Jon ColemanEVP, Chief Commercial Officer	$491.5K	$5.8M	—	$353.9K	$68.9K	$6.7M
Michael BrownEVP, Chief Legal Officer	$631.6K	$5.2M	—	$454.8K	$15.0K	$6.3M
Sadie SternEVP, Chief Human Resources Officer	$571.2K	$5.2M	—	$411.3K	$28.2K	$6.3M